Is this you? Create Your Porfile
Avatar

Gita Camilla Tejlgaard Kampen

Novo Nordisk

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Gita Camilla Tejlgaard Kampen is active.

Explore More

Publication

Featured researches published by Gita Camilla Tejlgaard Kampen.

Archive | 2004

NEW AMIDE DERIVATIVES AND PHARMACEUTICAL USE THEREOF

Henrik Sune Andersen; Gita Camilla Tejlgaard Kampen; Inge Thøger Christensen; John Patrick Mogensen; Annette Rosendal Larsen; John Paul Kilburn

Archive | 2006

Pharmaceutical use of substituted amides

Henrik Sune Andersen; Anker Steen Jorgensen; John Paul Kilburn; Gita Camilla Tejlgaard Kampen; Soren Ebdrup

Archive | 2004

Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent

Gita Camilla Tejlgaard Kampen; Henrik Sune Andersen

Archive | 2004

COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST

Gita Camilla Tejlgaard Kampen; Henrik Sune Andersen

Archive | 2004

Pharmaceutical use of fused 1,2,4-triazoles

Henrik Sune Andersen; Gita Camilla Tejlgaard Kampen; Inge Thøger Christensen; John Patrick Mogensen; Annette Rosendal Larsen

Archive | 2004

Pharmaceutical use of substituted 1,2,4-triazoles

Henrik Sune Andersen; Gita Camilla Tejlgaard Kampen; Inge Thøger Christensen; John Patrick Mogensen; Annette Rosendal Larsen

Archive | 2004

NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF

Henrik Sune Andersen; Gita Camilla Tejlgaard Kampen; Inge Thoeger Christensen; John Patrick Mogensen; Annette Rosendal Larsen

Archive | 2005

Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy

Gita Camilla Tejlgaard Kampen; Henrik Sune Andersen

Archive | 2007

Pharmaceutical use of substituted piperidine carboxamides

John Paul Kilburn; Gita Camilla Tejlgaard Kampen; Henrik Sune Andersen

Archive | 2005

Combination Therapy Using an 11Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders

Gita Camilla Tejlgaard Kampen; Henrik Sune Andersen

Explore More

Collaboration

Dive into the Gita Camilla Tejlgaard Kampen's collaboration.

Top Co-Authors
Avatar

Henrik Sune Andersen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Annette Rosendal Larsen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

John Patrick Mogensen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

John Paul Kilburn

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Inge Thøger Christensen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Inge Th Ger Christensen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Anker Steen Jorgensen

Novo Nordisk

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge